FDA releases 24 new, 14 revised product-specific guidances

By KEDEST TADESSE, MS, RAC | May. 20, 2022

Several new and revised product-specific guidance documents published this week by the FDA’s Office of Generic Drugs provide recommendations for the development of various generic drug products, including several complex generics.